Aug 13, 2026 04:05PM
Aug 12, 2026 04:01PM
Jul 27, 2026 08:04AM
Jul 27, 2026 08:00AM
May 14, 2026 04:10PM
May 13, 2026 04:01PM
Apr 21, 2026 08:30AM Journey Medical secures third major GPO contract for Emrosi rosacea drug
Apr 21, 2026 08:30AM
Mar 31, 2026 04:05PM
Mar 30, 2026 04:05PM
Mar 30, 2026 04:05PM
Mar 25, 2026 04:01PM
Feb 23, 2026 09:24AM
Feb 23, 2026 09:24AM UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Feb 23, 2026 08:30AM
Feb 23, 2026 08:30AM
Jan 13, 2026 07:45AM
Jan 13, 2026 07:45AM
Dec 15, 2025 08:03AM
Dec 15, 2025 08:00AM
Dec 10, 2025 08:30AM Journey Medical publishes Emrosi clinical trial results in dermatology journal
Dec 10, 2025 08:30AM
Nov 14, 2025 08:30AM
Nov 12, 2025 04:01PM
Nov 6, 2025 07:01AM
Nov 6, 2025 07:00AM
Oct 24, 2025 08:30AM
Oct 24, 2025 08:30AM Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
Oct 21, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 1, 2025 08:05AM
Oct 1, 2025 08:00AM
Aug 14, 2025 04:05PM
Aug 12, 2025 04:01PM
Aug 7, 2025 08:30AM Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
Aug 7, 2025 08:30AM
Jul 14, 2025 08:31AM
Jul 14, 2025 08:30AM
Jul 7, 2025 08:32AM
Jul 7, 2025 08:30AM
Jun 24, 2025 08:31AM
Jun 24, 2025 08:30AM Journey Medical to Join Russell 2000® and Russell 3000® Indexes
Jun 20, 2025 08:32AM
Jun 20, 2025 08:30AM
Jun 9, 2025 08:30AM
May 30, 2025 10:48AM
May 30, 2025 10:47AM
May 15, 2025 04:05PM
May 14, 2025 04:01PM Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 13, 2025 04:15PM

1,186,123 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All